BHC
Bausch Health Companies Inc.
$7.02
+$0.41(+6.20%)
65
Overall
40
Value
91
Tech
--
Quality
Market Cap
$3.14B
Volume
3.27M
52W Range
$4.25 - $9.85
Target Price
$7.08
Order:
Income Statement
| Metric | Trend | Chart | 2015 Dec | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $10.4B | $9.7B | $8.7B | $8.4B | $8.6B | $8.0B | $8.4B | $8.1B | $8.8B | $9.6B | ||
| Total Revenue | $10.3B | $9.5B | $8.7B | $8.4B | $8.6B | $8.0B | $8.4B | $8.1B | $8.8B | $9.6B | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | $-2.5B | $-2.6B | $-2.5B | $-2.3B | $53.0M | $2.2B | $2.4B | $2.4B | $2.6B | -- | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $5.6B | $4.4B | $3.5B | $3.4B | $8.5B | $5.8B | $6.0B | $5.8B | $8.8B | $6.8B | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $3.1B | $3.3B | $2.6B | $2.9B | $4.4B | $3.3B | $3.5B | $4.4B | $3.5B | $4.2B | ||
| Research & Development | $440.0M | $455.0M | $366.0M | $413.0M | $471.0M | $452.0M | $465.0M | $529.0M | $604.0M | $616.0M | ||
| Research Expense | $440.0M | $455.0M | $366.0M | $413.0M | $471.0M | $452.0M | $465.0M | $529.0M | $604.0M | $616.0M | ||
| Selling, General & Administrative | $2.7B | $2.8B | $2.6B | $2.5B | $2.6B | $2.4B | $2.6B | $2.6B | $2.9B | $3.3B | ||
| Selling & Marketing Expenses | $2.7B | $2.8B | $2.6B | $2.5B | $544.0M | $451.0M | $515.0M | $518.0M | $625.0M | $786.0M | ||
| General & Administrative Expenses | $-85.0M | $-84.0M | $-102.0M | $-92.0M | $2.6B | $2.4B | $2.6B | $2.6B | $2.9B | $3.3B | ||
| Promotion & Advertising | $-652.0M | $-564.0M | $-462.0M | $-481.0M | $544.0M | $451.0M | $515.0M | -- | -- | -- | ||
| Salaries & Wages | $-140.0M | $-165.0M | $-87.0M | $-87.0M | $102.0M | $105.0M | $128.0M | -- | -- | -- | ||
| Depreciation & Amortization | $-2.5B | $-2.9B | $-2.9B | $-175.0M | $178.0M | $180.0M | $177.0M | $179.0M | $187.0M | $190.0M | ||
| Depreciation & Amortization | $-2.5B | $-2.9B | $-2.9B | $-175.0M | $178.0M | $180.0M | $177.0M | -- | -- | -- | ||
| Amortization | $-145.3M | $-5.0M | -- | $-2.0M | $-18.0M | $-217.0M | $12.5B | $11.5B | $11.2B | $11.1B | ||
| Other Operating Expenses | $-27.0M | $73.0M | $-353.0M | $-20.0M | $1.4B | $502.0M | $373.0M | $35.0M | $28.0M | $247.0M | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $2.5B | $1.1B | $891.0M | $519.0M | $-203.0M | $676.0M | $450.0M | $454.0M | $963.0M | $1.5B | ||
| EBITDA | $1.2B | $-1.2B | $-440.0M | $-1.2B | $376.0M | $2.4B | $2.0B | $2.8B | $2.2B | $2.9B | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | -- | -- | -- | $1.7B | $1.6B | $1.5B | $1.4B | $1.5B | $1.3B | $1.4B | ||
| Interest Income Operating | $170.3M | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Intinc | $4.0M | $8.0M | $12.0M | $11.0M | $12.0M | $13.0M | $7.0M | $14.0M | $26.0M | $33.0M | ||
| Net Non-Operating Interest Income/Expense | $-1.6B | $-1.8B | $-1.8B | $-1.7B | $-1.6B | $-1.5B | $-1.4B | $-1.4B | $-1.3B | $-1.4B | ||
| Other Income/Expense | $315.0M | $-19.0M | $-167.0M | $110.0M | $54.0M | $59.0M | $62.0M | $-69.0M | $-1.0M | $-23.0M | ||
| Other Special Charges | $-315.0M | $-73.0M | $-122.0M | $-119.0M | $-42.0M | $-59.0M | $-62.0M | $875.0M | $1.0M | $23.0M | ||
| SPECIAL ITEMS | ||||||||||||
| Restructring And Mn A Income | $362.0M | $132.0M | $52.0M | $22.0M | $31.0M | $-302.0M | $-269.0M | -- | -- | -- | ||
| Special Income Charges | $-666.0M | $-1.6B | $-1.1B | $-2.9B | $-106.0M | $-114.0M | $-234.0M | $-15.0M | $-54.0M | $-29.0M | ||
| Impairment of Capital Assets | $304.0M | $1.5B | $1.0B | $2.9B | $75.0M | $114.0M | $234.0M | $15.0M | $54.0M | $29.0M | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $-1.4B | $-4.2B | $-3.4B | $-4.1B | $-1.8B | $600.0M | $402.0M | $1.3B | $938.0M | $1.6B | ||
| Pre-Tax Income | $-155.0M | $-2.4B | $-1.7B | $-4.2B | $-1.8B | $-934.0M | $-1.0B | $-129.0M | $-390.0M | $167.0M | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $133.0M | $-27.0M | $-4.1B | $-10.0M | $-54.0M | $-375.0M | $-87.0M | $83.0M | $221.0M | $239.0M | ||
| NET INCOME | ||||||||||||
| Net Income | $-292.0M | $-2.4B | $2.4B | $-4.1B | $-1.8B | $-560.0M | $-948.0M | $-225.0M | $-592.0M | $-46.0M | ||
| Net Income (Continuing Operations) | $-292.0M | $-2.4B | $2.4B | $-4.1B | $-1.8B | $-560.0M | $-948.0M | $-212.0M | $-611.0M | $-72.0M | ||
| Net Income (Discontinued Operations) | $-292.0M | $-2.4B | $2.4B | $-4.1B | $-1.8B | $-560.0M | $-948.0M | $-225.0M | $-592.0M | $-46.0M | ||
| Net Income (Common Stockholders) | $-292.0M | $-2.4B | $2.4B | $-4.1B | $-1.8B | $2.8B | $-948.0M | $-225.0M | $-592.0M | $-46.0M | ||
| TOTALS | ||||||||||||
| Total Expenses | $608.0M | $766.0M | $89.0M | $557.0M | $4.5B | $3.4B | $3.5B | $6.7B | $3.5B | $4.2B | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $342.7M | $347.3M | $350.2M | $351.3M | $352.1M | $355.0M | $358.9M | $362.0M | $364.9M | $368.0M | ||
| Average Shares Outstanding (Diluted) | $342.7M | $347.3M | $351.8M | $351.3M | $352.1M | -- | $358.9M | $362.0M | $364.9M | $368.0M | ||
| Shares Outstanding | $343.0M | $347.8M | $348.8M | $351.0M | $352.7M | $355.6M | $359.6M | $362.0M | $365.4M | $367.9M | ||
| Basic EPS | $-0.85 | $-6.94 | $6.86 | $-11.81 | $-5.08 | $-1.58 | $-2.64 | $-0.62 | $-1.62 | $-0.13 | ||
| Basic EPS (Continuing Operations) | -- | -- | -- | -- | $-5.08 | $-1.58 | $-2.64 | $-0.62 | $-1.62 | $-0.13 | ||
| Diluted EPS | $-0.85 | $-6.94 | $6.83 | $-11.81 | $-5.08 | $-1.58 | $-2.64 | $-0.62 | $-1.62 | $-0.13 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | -- | $-5.08 | -- | $-2.64 | $-0.62 | $-1.62 | $-0.13 | ||
| OTHER METRICS | ||||||||||||
| Acquired In Process Rn D | $56.8M | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Acquisition Expense | -- | -- | -- | -- | $8.0M | $48.0M | $11.0M | $29.0M | $24.0M | $4.0M | ||
| Gain On Sale Of P P E | $-8.0M | $6.0M | $-37.0M | $-6.0M | $31.0M | $1.0M | $2.0M | $5.0M | $3.0M | $10.0M | ||
| Interest Expense Operating | $-1.3B | $-1.7B | $-1.7B | $-1.7B | $-1.5B | $-1.5B | $-1.4B | -- | -- | -- | ||
| Minority Interests | $-4.0M | $-1.0M | $9.0M | $-4.0M | $-5.0M | $-1.0M | $-11.0M | $-13.0M | $19.0M | $26.0M | ||
| Non Recurring Operation Expense | $37.0M | $59.0M | $226.0M | $-27.0M | $1.4B | $422.0M | $356.0M | $9.0M | $-53.0M | $220.0M | ||
| Other Gand A | $-85.0M | $-84.0M | $-102.0M | $-92.0M | $2.6B | $2.4B | $2.6B | $2.6B | $2.9B | $3.3B | ||
| Other Impairment Of Capital Assets | -- | -- | -- | -- | $58.0M | -- | -- | -- | -- | -- | ||
| Other Taxes | $72.4M | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Other Write Off | -- | -- | -- | -- | $-1.0M | $-3.0M | $-2.0M | -- | -- | -- | ||
| Rent And Landing Fees | $-85.0M | $-84.0M | $-102.0M | $-92.0M | -- | -- | -- | -- | -- | -- | ||
| Selling Expense | $2.7B | $2.8B | $2.6B | $2.5B | -- | -- | -- | -- | -- | -- | ||
| Othspecchg | $-11.2M | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Restruct | $362.0M | $132.0M | $52.0M | $22.0M | $31.0M | $-302.0M | $-269.0M | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BHC | $7.02 | +6.2% | 3.27M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Bausch Health Companies Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW